PSA testing may be the first step in prostate cancer screening, but benign factors may contribute to high PSA, including aging, infection, and more.

A pelvic MRI scan with IV contrast and rectal balloon is highly effective in identifying local recurrence even at low PSA values in prostate cancer patients with a rising or persistently elevated PSA ...

Post-RP prognosis was distinguishable at a nadir PSA level of ≤0.03 ng/mL vs higher. A PSA level of 0.04 ng/mL or higher may optimally define PSA persistence in patients who have had radical ...

Radical prostatectomy does not ensure a cure, with one in three men experiencing cancer recurrence and elevated PSA levels within 10 years post-surgery. Significant side effects of prostate removal ...

Data from a prospective study showed that the IsoPSA prostate cancer test outperformed total PSA and free PSA in men 50 years or older with elevated PSA level. The FDA has approved the IsoPSA in vitro ...

A 65-year-old male patient initially presented with a PSA of 10 ng/mL. A 65-year-old male patient initially presented with a PSA of 10 ng/mL. He ultimately underwent a prostate needle biopsy, with 3 ...

Prostate cancer is common. About 200 in every 1,000 Australian men will be told they have prostate cancer by the age of 85. But the chance of dying from it is much lower: around 18 in 1,000 cases.

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about the role of PSMA-PET Imaging versus PSA. Prostate specific antigen (PSA) is a ...

An artificial intelligence–digital pathology algorithm to predict outcomes in a cohort of men diagnosed with prostate cancer within a low resource setting.

Prostate cancer is one of the most common cancers in men, but when caught early, it’s highly treatable. For Vernon Owens, a routine check-up at UConn Health led to an early diagnosis that may have ...

Prostate cancer is the second most common cancer in US men. Guidelines for screening vary, underscoring the need to engage patients in shared decision-making and counsel them about potential benefits ...